Purchase Order 36C24221P1652

Award Date 9/24/21
Potential Completion Date 2/16/23
Potential Value $318K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs awarded a $286,087.75 firm-fixed-price purchase order contract to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the provision of COVID-19 sequencing reagents. The contract supports the Indianapolis VA Medical Center's use of Life Technologies' Torrent Genexus sequencing instrument to test for SARS-CoV-2 variants. The contract provides sequencing assay panels, kits, chips, plates, seals, barcodes, and pipette tips compatible with...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for COVID-19 sequencing reagents. The $241,173.22 contract has a performance period through September 13, 2023 and does not have a set-aside designation. Life Technologies has previously served as a prime contractor for various federal agencies, including the National Institutes of Health,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA VISN 2) awarded a $335,250 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 2000 Sequencing System. The solicitation sought to sole source this acquisition to support COVID sequencing efforts at the James J. Peters VA Medical Center. The Research department requires this sequencing instrument to conduct analysis of COVID samples. No subcontractors or set aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $369,834.89 firm-fixed price purchase order to Fisher Scientific Company L.L.C. to supply genomic sequencing products and services in support of the VA's SeqForce program. The special notice solicitation sought a vendor to provide a Qubit Flex fluorometer, ThermoFisher Ion Torrent Chef system, and Ion GeneStudio S5 Next Generation Sequencer, along with requisite reagents, controls,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $414,823 firm fixed price purchase order to Fisher Scientific Company L.L.C. Fisher Healthcare Division for an ION TORRENT INTEGRATED SEQUENCER. The contract has a period of performance from June 23, 2022 through July 22, 2022 for delivery of the sequencer to a location in Snyder, New York. The original solicitation sought to procure the Fisher Scientific Genexus Integrated...
The Department of Veterans Affairs awarded a $340,375.86 firm fixed price purchase order to Thermo Fisher Scientific (Asheville) LLC Laboratory Products Division for a Genexus Sequencer system. Per the original sole source solicitation notice, Thermo Fisher will provide the Genexus and Genexus Purification System to the Indianapolis VA Medical Center, along with installation, operational qualification, process validation, and analytical validation support services. This award supports the VA's...
The Department of Veterans Affairs Veterans Health Administration awarded a $102,260.20 firm fixed price definitive contract to Life Technologies Corporation, a for-profit manufacturer, to provide a PM ON 7900HT Sequence Detection System and associated supplies for a base period of 12 months with a 12-month option. The contract supports the Veterans Integrated Service Network 2 located in Bronx, New York and does not utilize any set-aside designation. Life Technologies is a subsidiary of...
The Department of Veterans Affairs Veterans Health Administration has awarded a $190,681.90 firm-fixed-price delivery order contract to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, for the supply of reagents for ThermoFisher's next-generation sequencing (NGS) and Genexus genetic analysis platforms. The contract will run through January 31, 2024 and does not utilize any set-aside designation. Life Technologies, as the prime contractor, will provide specialized...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $95,955 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a GRIDION MK1 sequencing machine. The sole source award is in response to solicitation 6505 for the intent to acquire a GridION Mk1 sequencing device from Nanopore Technologies for the James J. Peters VA Medical Center in Bronx, New York. The sequencing machine and associated assurance, software license,...
The Department of Veterans Affairs Veterans Health Administration awarded a $595,418 firm-fixed-price blanket purchase agreement call contract to Fisher Scientific Company L.L.C., doing business as Fisher Healthcare, a division of Thermo Electron Corporation Financial Services. The contract is for the delivery of a Genexus Integrated Sequencer System instrument and reagents to support COVID-19 variant identification efforts at VA facilities in Veterans Integrated Service Network 19. Place of...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $317,936 firm fixed price purchase order to Life Technologies Corporation to provide a ThermoFisher Ion Torrent Genexus Integrated Sequencer and associated equipment and training. The solicitation sought this sequencing platform and compatible consumables to support COVID-19 testing by the James J. Peters Bronx VA Medical Center's Pathology and Laboratory Service. Market research found Life Technologies to be the only supplier able to meet the medical center's needs without disrupting established testing protocols or compromising result validity. The sequencing equipment, various consumables and plates, installation, and training will allow the Pathology and Laboratory Service to establish COVID-19 testing capacity using its existing standards and throughput. Performance will take place in Grand Island, New York over 16 months from September 2021 through February 2023.

Generated 12/29/23, 3:47 PM